Skip to content

Insentials

Active
Private limited companyfounded 2021active for 5 yearsGentsesteenweg 194, 9800 Deinze, BelgiumKBO/BCE: BE 0765.136.889
Summary

Insentials has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.9m and a net result of €279,180. Equity is growing by about 76% per year across the filed financial years. Its solvency ranks better than 86% of 997 sector peers (NACE 10, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Overview

Activity
Manufacture of food products
NACE 10890Other retail sale of food NACE 47279
1 site
Size
€4.0mtotal assets 2025
Staff
13.9 FTE
Equity
€2.9m
Profit
€279,180
Turnover not published (abbreviated or micro format)
Financial health
68 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.1%
Structure
Holdings
1
  • Eutopia Gestion SASDirector · permanent representative Antoine Fine
  • FG InvestmentDirector · permanent representative Evrard de Montgolfier
Accounts 7 days early4 of 7 deeds read
Why 68raises risk2 changes of registered office in 24 monthsFounded in 2021lowers riskSize: 13.9 FTE, total assets €4.0mLiquidity: current ratio 3.42, cash €1.6mShow the evidence

Checked score

Score 2025
68 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 72% of its sector peers (NACE 10, small)
Financial strength · tick = 2024
Strong
Solvency 98+4
equity 73.1% of total assets
Liquidity 89+3
short-term debt 24.6% · cash 38.7%
Profitability 63-37
return on assets 7.0%
Bankruptcy probability, 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.5% (629 companies, NACE 10, small)
Last 24 months 11-2024: 0.6%lowest value 12-2024: 2.7%▲ +2.1 percentage points vs 11-2024 01-2025: 2.6%▼ -0.1 percentage points vs 12-2024 02-2025: 2.6%● unchanged vs 01-2025 03-2025: 2.6%● unchanged vs 02-2025 04-2025: 2.9%▲ +0.3 percentage points vs 03-2025 05-2025: 2.9%● unchanged vs 04-2025 06-2025: 3.0%▲ +0.1 percentage points vs 05-2025 07-2025: 3.2%▲ +0.2 percentage points vs 06-2025highest value 08-2025: 2.2%▼ -1.0 percentage point vs 07-2025 09-2025: 2.2%● unchanged vs 08-2025 10-2025: 2.2%● unchanged vs 09-2025 11-2025: 2.2%● unchanged vs 10-2025 12-2025: 2.2%● unchanged vs 11-2025 01-2026: 2.2%● unchanged vs 12-2025 02-2026: 2.2%● unchanged vs 01-2026 03-2026: 2.5%▲ +0.3 percentage points vs 02-2026 04-2026: 2.7%▲ +0.2 percentage points vs 03-2026 05-2026: 2.7%● unchanged vs 04-2026 06-2026: 2.9%▲ +0.2 percentage points vs 05-2026 07-2026: 3.1%▲ +0.2 percentage points vs 06-2026 08-2026: 1.1%▼ -2.0 percentage points vs 07-2026 09-2026: 1.1%● unchanged vs 08-2026 10-2026: 1.1%● unchanged vs 09-2026
Credit of up to €190,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.42, compared with 2.89 in 2024, above the usual 1.5; short-term debt: 24.6% and cash: 38.7% of total assets), and 26.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 10, small): better than 90% on solvency, 97% on liquidity, 37% on profitability and 62% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 2 changes of registered office in 24 months
Belgian Official Gazette
lowers risk · Size: 13.9 FTE, total assets €4.0m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 3.42, cash €1.6m
NBB · annual accounts
raises risk · Founded in 2021
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
7 days early
2024
8 days early
2023
20 days late
2022
31 days late
2021
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 13 days after the deadline; the sector median (NACE 10) for financial year 2024 is 4 days before the deadline, and 38% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
22-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Registered officeDirector in office · Registered-office…

Financials · financial year 2025, abbreviated format

Equity
€2.9m▲ 10.5%
2024 · €2.7m
Total assets
€4.0m▲ 4.6%
2024 · €3.8m
Net result
€279,180▼ 81.5%
2024 · €1.5m
Working capital
€2.4m▲ 10.5%
2024 · €2.2m
Trend over the years

2021 to 2025, 5 financial years

The operating result falls in 2025; 2025 is 74% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.6m 2025 Net result€0.3m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 10, Manufacture of food products: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20212022202320242025
Operating result€0.006m-€0.1m▲ 2,214%€1.3m▲ 811%€2.1m▲ 64.0%€0.6m▼ 73.8%
Net result€0.002mwithin the sector's middle half-€0.1mabove the sector's middle half▲ 6,567%€0.9mabove the sector's middle half▲ 698%€1.5mabove the sector's middle half▲ 59.3%€0.3mabove the sector's middle half▼ 81.5%
Equity€0.1mabove the sector's middle half-€0.2mabove the sector's middle half▲ 54.4%€1.1mabove the sector's middle half▲ 485%€2.7mabove the sector's middle half▲ 132%€2.9mabove the sector's middle half▲ 10.5%
Total assets€0.3mwithin the sector's middle half-€0.4mabove the sector's middle half▲ 61.0%€2.2mabove the sector's middle half▲ 383%€3.8mabove the sector's middle half▲ 78.1%€4.0mabove the sector's middle half▲ 4.6%
Debt€0.2m-€0.3m▲ 66.6%€1.0m▲ 304%€1.2m▲ 17.0%€1.1m▼ 8.8%
Working capital€0.1mabove the sector's middle half-€0.2mabove the sector's middle half▲ 46.8%€1.0mabove the sector's middle half▲ 412%€2.2mabove the sector's middle half▲ 119%€2.4mabove the sector's middle half▲ 10.5%
Solvency45.7%within the sector's middle half-43.9%within the sector's middle half▼ 1.9pp53.1%within the sector's middle half▲ 9.2pp69.2%above the sector's middle half▲ 16.1pp73.1%above the sector's middle half▲ 3.9pp
Current ratio3.81above the sector's middle half-2.36above the sector's middle half▼ 1.451.98within the sector's middle half▼ 0.382.89above the sector's middle half▲ 0.913.42above the sector's middle half▲ 0.54
Return on assets (ROA)0.6%within the sector's middle half-26.6%above the sector's middle half▲ 26.0pp44.0%above the sector's middle half▲ 17.4pp39.4%above the sector's middle half▼ 4.6pp7.0%within the sector's middle half▼ 32.4pp
Staff (FTE)38within the sector's middle half▲ 167%13.9above the sector's middle half▲ 73.8%
above within below the middle half of NACE 10, Manufacture of food products: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Why a figure moved sharply
  • 2024 Net result +59%, Staff (FTE) +167% on 2023. The accounts now follow the abbreviated format, last year the micro format.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.0m
Fixed assets €633,448 ▲ 20.5%
Current assets €3.4m ▲ 2.0%
Equity and liabilities €4.0m
Equity €2.9m ▲ 10.5%
Debt €1.1m ▼ 8.8%
Debt's share of the balance-sheet total falls from 30.8% to 26.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€676,272▼
2024 · €2.2m
Cash flow
€401,541▼
2024 · €1.6m
Quick ratio
2.40▲
2024 · 1.70
Debt to equity
0.37▼
2024 · 0.45
ROE
9.5%▼
2024 · 56.9%
Interest coverage
4.21▼
2024 · 19.50
Debt ≤ 1 year
€988,686▼
2024 · €1.1m
Debt > 1 year
€55,582▲
2024 · €34,846
Income taxes
€114,353▼
2024 · €490,193
Staff costs
€833,496▲
2024 · €533,615
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,782 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 96.7% are still going.

  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.6% went bankrupt
2.7% stopped otherwise
96.7% still going

For this company itself Checked computes a higher bankruptcy probability: 1.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,782 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet Code20242025
Assets
Total assets20/58€3.8m€4.0m▲
Fixed assets21/28€0.5m€0.6m▲
Intangible fixed assets21€0.3m€0.3m▼
Tangible fixed assets22/27€0.2m€0.3m▲
Plant, machinery and equipment23€269€0.008m▲
Furniture and vehicles24€0.1m€0.1m▼
Other tangible fixed assets26€0.1m€0.2m▲
Financial fixed assets28€0.008m€0.009m▲
Current assets29/58€3.3m€3.4m▲
Stocks and contracts in progress3€1.4m€1.0m▼
Stocks30/36€1.4m€1.0m▼
Amounts receivable within one year40/41€0.5m€0.7m▲
Trade receivables40€0.3m€0.4m▲
Other amounts receivable41€0.2m€0.2m▲
Cash at bank and in hand54/58€1.5m€1.6m▲
Deferred charges and accrued income490/1€0.009m€0.1m▲
Equity and liabilities
Total equity and liabilities10/49€3.8m€4.0m▲
Equity10/15€2.7m€2.9m▲
Contributions10/11€0.1m€0.1m=
Reserves13€0.6m€0.8m▲
Tax-exempt reserves132€0.6m€0.8m▲
Profit (loss) carried forward14€2.0m€2.0m▲
Amounts payable17/49€1.2m€1.1m▼
Amounts payable after more than one year17€0.03m€0.06m▲
Financial debts170/4€0.03m€0.06m▲
Amounts payable within one year42/48€1.1m€1.0m▼
Current portion of amounts payable after more than one year42€0.008m€0.02m▲
Trade debts44€0.9m€0.8m▼
Suppliers440/4€0.9m€0.8m▼
Taxes, remuneration and social security45€0.07m€0.1m▲
Taxes450/3€0.01m€0.02m▲
Remuneration and social security454/9€0.06m€0.09m▲
Other amounts payable47/48€0.1m€0.05m▼
Accrued charges and deferred income492/3-€0.04m
Income statement Code20242025
Remuneration, social security and pensions62€0.5m€0.8m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.05m€0.1m▲
Other operating charges640/8€0.09m€0.01m▼
Non-recurring operating charges66A€0-
Gross operating margin9900€2.8m€1.5m▼
Operating profit (loss)9901€2.1m€0.6m▼
Financial income75/76B€0.003m€179▼
Recurring financial income75€0.003m€179▼
Financial charges65/66B€0.1m€0.2m▲
Recurring financial charges65€0.1m€0.2m▲
Profit (loss) for the period before taxes9903€2.0m€0.4m▼
Income taxes67/77€0.5m€0.1m▼
Profit (loss) for the period9904€1.5m€0.3m▼
Transfer to tax-exempt reserves689€0.6m€0.2m▼
Profit (loss) for the period to be appropriated9905€1.0m€0.07m▼
Appropriation of the result
Profit (loss) to be appropriated9906€2.0m€2.0m▲
Profit (loss) brought forward from the previous period14P€1.0m€2.0m▲
Social balance sheet
Average headcount (FTE)90878.013.9▲

The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62-€0.05m€0.3m€0.5m€0.8m▲ 56.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.01m€0.02m€0.01m€0.05m€0.1m▲ 127%
Other operating charges640/8-€0.005m€0.001m€0.09m€0.01m▼ 89.5%
Non-recurring operating charges66A--€0.04m€0--
Gross operating margin9900€0.02m€0.2m€1.6m€2.8m€1.5m▼ 45.6%
Operating profit (loss)9901€0.006m€0.1m€1.3m€2.1m€0.6m▼ 73.8%
Financial income75/76B€30€0€0.003m€0.003m€179▼ 94.8%
Recurring financial income75€30€0€0.003m€0.003m€179▼ 94.8%
Financial charges65/66B€0.004m€0.005m€0.03m€0.1m€0.2m▲ 44.6%
Recurring financial charges65€0.004m€0.005m€0.03m€0.1m€0.2m▲ 44.6%
Profit (loss) for the period before taxes9903€0.002m€0.1m€1.3m€2.0m€0.4m▼ 80.4%
Income taxes67/77-€0.02m€0.3m€0.5m€0.1m▼ 76.7%
Profit (loss) for the period9904€0.002m€0.1m€0.9m€1.5m€0.3m▼ 81.5%
Transfer to tax-exempt reserves689---€0.6m€0.2m▼ 62.4%
Profit (loss) for the period to be appropriated9905€0.002m€0.1m€0.9m€1.0m€0.07m▼ 92.8%
Line20212022202320242025Change
Assets
Total assets20/58€0.3m€0.4m€2.2m€3.8m€4.0m▲ 4.6%
Fixed assets21/28€0.1m€0.1m€0.2m€0.5m€0.6m▲ 20.5%
Intangible fixed assets21€0.1m€0.09m€0.1m€0.3m€0.3m▼ 7.3%
Tangible fixed assets22/27-€0.02m€0.04m€0.2m€0.3m▲ 58.0%
Plant, machinery and equipment23-€0.003m€0.001m€269€0.008m▲ 2,931%
Furniture and vehicles24-€0.007m€0.02m€0.1m€0.1m▼ 0.1%
Other tangible fixed assets26-€0.008m€0.02m€0.1m€0.2m▲ 126%
Financial fixed assets28-€0.008m€0.008m€0.008m€0.009m▲ 13.3%
Current assets29/58€0.2m€0.3m€2.0m€3.3m€3.4m▲ 2.0%
Stocks and contracts in progress3€0.01m€0.03m€0.2m€1.4m€1.0m▼ 26.0%
Stocks30/36€0.01m€0.03m€0.2m€1.4m€1.0m▼ 26.0%
Amounts receivable within one year40/41€0.08m€0.1m€1.1m€0.5m€0.7m▲ 47.3%
Trade receivables40€0.02m€0.07m€0.5m€0.3m€0.4m▲ 66.2%
Other amounts receivable41€0.06m€0.04m€0.6m€0.2m€0.2m▲ 22.4%
Cash at bank and in hand54/58€0.08m€0.2m€0.7m€1.5m€1.6m▲ 5.2%
Deferred charges and accrued income490/1€0.005m€0€0.009m€0.009m€0.1m▲ 1,361%
Equity and liabilities
Total equity and liabilities10/49€0.3m€0.4m€2.2m€3.8m€4.0m▲ 4.6%
Equity10/15€0.1m€0.2m€1.1m€2.7m€2.9m▲ 10.5%
Contributions10/11€0.1m€0.1m€0.1m€0.1m€0.1m=
Reserves13---€0.6m€0.8m▲ 37.6%
Tax-exempt reserves132---€0.6m€0.8m▲ 37.6%
Profit (loss) carried forward14€0.002m€0.07m€1.0m€2.0m€2.0m▲ 3.5%
Amounts payable17/49€0.2m€0.3m€1.0m€1.2m€1.1m▼ 8.8%
Amounts payable after more than one year17€0.1m€0.1m€0€0.03m€0.06m▲ 59.5%
Financial debts170/4€0.1m€0.1m€0€0.03m€0.06m▲ 59.5%
Amounts payable within one year42/48€0.05m€0.1m€1.0m€1.1m€1.0m▼ 13.9%
Current portion of amounts payable after more than one year42---€0.008m€0.02m▲ 107%
Trade debts44€0.05m€0.08m€0.6m€0.9m€0.8m▼ 12.7%
Suppliers440/4€0.05m€0.08m€0.6m€0.9m€0.8m▼ 12.7%
Taxes, remuneration and social security45-€0.02m€0.3m€0.07m€0.1m▲ 44.4%
Taxes450/3-€0.02m€0.3m€0.01m€0.02m▲ 35.2%
Remuneration and social security454/9--€0.03m€0.06m€0.09m▲ 46.4%
Other amounts payable47/48-€0.05m€0.05m€0.1m€0.05m▼ 62.4%
Accrued charges and deferred income492/3----€0.04m-
Line20212022202320242025Change
Profit (loss) for the period9904€0.002m€0.1m€0.9m€1.5m€0.3m▼ 81.5%
+ Depreciation and write-downs630€0.01m€0.02m€0.01m€0.05m€0.1m▲ 127%
Operating cash flow (approximation)€0.01m€0.1m€1.0m€1.6m€0.4m▼ 74.4%
Investment in fixed assets (approximation)--€0.03m-€0.06m-€0.4m-€0.2m▲ 45.8%
Change in cash-€0.1m€0.5m€0.8m€0.08m▼ 90.5%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (5)
Financial year Type Filed Reference
31-12-2025 abbreviated format 24-07-2026 2026-00327986
31-12-2024 abbreviated format 23-07-2025 2025-00303700
31-12-2023 micro format 20-08-2024 2024-00357678
31-12-2022 micro format 31-08-2023 2023-00387274
31-12-2021 micro format 31-08-2022 2022-20410194

Similar companies · same sector, comparable size

Of the 391 active companies whose main activity is manufacture of food products (NACE 10890), figures are known for 223. 96 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2023 to 2025 · 5 entries · €49,997 awarded · €49,997 paid
Year Entries AwardedPaid
2025 1 €12,572€12,572
2024 2 €17,930€17,930
2023 2 €19,495€19,495
Schemes
3 entries · €40,037 · €40,037 paid · Departement Werk en Sociale Economie
1 entry · €9,000 · €9,000 paid · Vlaams Agentschap voor Internationaal Ondernemen
1 entry · €960 · €960 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
under verification, last change in 2024
This board is reconstructed from a single act (24447080). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.

Board 2

Eutopia Gestion SAS
Director (not named in the articles) · since 09-10-2024 · Legal entity · permanent representative: Antoine Fine
Current
FG Investment
Director (not named in the articles) · since 09-10-2024 · Legal entity · permanent representative: Evrard de Montgolfier
Current

Day-to-day management 1

PHARMAFOOD
Managing director · since 29-11-2024 · Private limited company · permanent representative: Amandine De Paepe
Current

Permanent representatives 3

Antoine Fine
Permanent representative · since 09-10-2024 · for Eutopia Gestion SAS
Current
Evrard de Montgolfier
Permanent representative · since 09-10-2024 · for FG Investment
Current
Amandine De Paepe
Permanent representative · since 29-11-2024 · for PHARMAFOOD
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 7 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

3 people since 2024, 3 in office
Show
  • Board
  • Day-to-day management
Mandates per person, with start and end dates
Name Functions and periods
Eutopia Gestion SAS
  • Director, from 09-10-2024 to date
FG Investment
  • Director, from 09-10-2024 to date
PHARMAFOOD
  • Managing director, from 29-11-2024 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 29-11-2024 Capital stated in the deed · 100 shares

Group and network

Holdings and subsidiaries

1 holding

Holdings 1

According to the 2025 annual accounts of Insentials and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

2 current directors
Depth

The board mandates are listed below; here you explore them as a network.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

Insentials was incorporated on 12 March 2021 as a private limited company.1 The registered office moved to Drongen in 2023, to Sint-Martens-Latem in 2024 and to Deinze in 2025.234 Total assets rose from €277,245 in 2021 to €4.0m in 2025 and headcount from 3 full-time equivalents in 2023 to 13.9 in 2025.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 14-12-2023
  3. 3Belgian Official Gazette, 25-11-2024
  4. 4Belgian Official Gazette, 24-01-2025
  5. 5National Bank, annual accounts 2021, 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
24-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
23-07
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
24-01
Gazette deed Registered office
Director in office · Registered-office move4 facts ▸
  • Other provision, “deposit reference”, 25012876 (deed in Dutch)
  • Board meeting, 04-10-2024
  • Director in office, Amandine De Paepe (sole director)
  • Registered-office move, Gentsesteenweg 194/0001-9800 Deinze
2024
31-12
Financial Highest result from 2021 to 2025net €1.5m ▲59.3%
Operating result €2.1m, net result €1.5m, both a record.
31-12
Financial Equity above €2mequity €2.7m ▲132%
A profit in every financial year since 2021 builds equity to €2.7m.
29-11
Gazette deed Appointments: FG Investment, Eutopia Gestion SAS and Pharmafood
Permanent representatives: Evrard de Montgolfier, Antoine Fine and Amandine De Paepe · Capital · Power of attorney16 facts ▸
  • Capital
  • Other provision, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Director appointment, FG Investment (director (not named in the articles))
  • Director appointment, Eutopia Gestion SAS (director (not named in the articles))
  • Director appointment, Pharmafood (managing director)
  • Permanent representative, Evrard de Montgolfier
  • Permanent representative, Antoine Fine
  • Permanent representative, Amandine De Paepe
  • Other provision, “info@insentials.com, website-e-mail” (deed in Dutch)
  • Power of attorney
  • General meeting, 14-11-2024
  • Kind of shares, “wijziging rechten tot afzonderlijke te creëren soort, zelfde rechten en voordelen,behoudens Aandeelhoudersovereenkomst” (deed in Dutch)
  • +4 further facts in this act
25-11
Gazette deed Appointments: FG Investment BV (director) and Eutopia Gestion SAS (director)
Permanent representatives: Evrard de Montgolfier, Antoine Fine and Amandine De Paepe · Power of attorney · Registered-office move12 facts ▸
  • General meeting, 09-10-2024
  • Director appointment, FG Investment BV (director)
  • Director appointment, Eutopia Gestion SAS (director)
  • Permanent representative, Evrard de Montgolfier
  • Permanent representative, Antoine Fine
  • Board composition, Pharmafood BV (director)
  • Board composition, FG Investment BV (director)
  • Board composition, Eutopia Gestion SAS (director)
  • Board meeting, 09-10-2024
  • Power of attorney, Pharmafood BV
  • Permanent representative, Amandine De Paepe (vaste vertegenwoordiger belast met uitvoering van mandaat van gedelegeerd bestuurder)
  • Registered-office move, Xavier de Cocklaan 13,9831 Sint-Martens-Latem
20-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 20 days late
2023
31-12
Financial Equity above €1mequity €1.1m ▲485%
A profit in every financial year since 2021 builds equity to €1.1m.
14-12
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 01-11-2023
  • Registered-office move, Keuzekouter 20-9031 Drongen
31-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 31 days late
2022
31-12
Financial Equity above €150,000equity €195,737 ▲54.4%
A profit in every financial year since 2021 builds equity to €195,737.
31-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
4 of 7 deeds read
About the unread acts

Of the 7 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded12-03-2021
Financial year end31-12
Activities, NACEBEL 2025
10890Manufacture of food products
47279Other retail sale of food
Contact
E-mail info@insentials.com
E-invoicing
Reachable via Peppol
Peppol ID 0208:0765136889
Also 9925:BE0765136889
Registered 10-08-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 22 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Deinzeunit no. 2.314.691.501
1 permission
Detailhandel LM>3 maand · since 21-01-2026

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Deinze · 1 establishment unit since 2021
registered office establishment The establishment unit on the map
Ground area
1,377 m²
Building footprint
852 m²
Building volume
2,730 m³
Parcel 44054A0501/00T002, Flanders · tallest building 12.5 m. Linked by address, not a title deed.
4 companies at this address See who is registered here
1 establishment unit
Insentials
Gentsesteenweg 194, 9800 DeinzeOther retail sale of food
since 2021unit no. 2.314.691.501
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
44054A0501/00T002 Flanders 1,376 m² 1 · 852 m² 12.5 m · 1
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“1/ De verkoop,fabricage en studie van voedingssupplementen,kruiden,sportproducten,thee,poeders,medical devices en andere voedingsmiddelen…” (deed in Dutch)
17 activities (deed in Dutch)
  1. 1/ De verkoop,fabricage en studie van voedingssupplementen,kruiden,sportproducten,thee,poeders,medical devices en andere voedingsmiddelen.
  2. 2/ De invoer,de uitvoer,doorvoer,opslag,de verkoop en het geven van franchise van bovenvermelde producten,evenals van grondstoffen en de moederlogen bestemd voor de bereiding van deze producten,alsook van planten,gewassen en etherische oliën,zonder dat deze opsomming beperkend is.
  3. 3/ Het schrijven van voedingsboeken.
  4. 4/ Het maken van alle farmaceutische,farmacologische en toxicologische studies en onderzoeken betreffende alle commerciële en industriële activiteiten,de organisatie van vennootschappen en ondernemingen,het verrichten van marktonderzoek en promotie.
  5. 5/ Het verlenen van advies en bijstand en het ontwikkelen van activiteiten in de farmaceutische sector en in de gezondheidssector en meer specifiek de voedingssupplementen.
  6. 6/ Praktijk als voedingsdeskundige.
  7. 7/ Het adviseren,ontwikkelen en uitvoeren van marketing acties voor derden.
  8. 8/ Het voeren van promotionele acties,van welke aard dan ook,voor derden.
  9. 9/ Het ontwerpen van publicitaire teksten,slogans en artikelen.
  10. 10/ Het verlenen van advies met betrekking tot informatie-en promotiecampagnes.
  11. 11/ Het outsourcen van medewerkers met als doel het geven van advies aan derden,het begeleiden van projecten of het uitvoeren van promotionele acties.- Het voeren van mediacampagnes voor derden.
  12. 12/ Het ter beschikking stellen van management;het voeren van bedrijfsmanagement in de meest ruime zin van het woord,daarin begrepen het uitoefenen van de functie van bestuurder,of vereffenaar van binnenlandse en buitenlandse vennootschappen;van het uitoefenen van bedrijfsleiding en het organiseren ervan;het optreden als mandataris voor alle binnenlandse en buitenlandse vennootschappen;alsook het waarnemen van beheer op alle niveaus,zowel voor eigen rekening als voor rekening of in deelneming met derden.
  13. 13/ Het oprichten van gebouwen of laten oprichten van gebouwen,het verwerven,beheren,exploiteren,huren en verhuren,vervreemden van onroerende zaken en/of zakelijke rechten op onroerende goederen,hetzij voor eigen rekening hetzij voor rekening van derden in de ruimste zin van het woord.
  14. Alle onroerend en roerend goed verrichtingen uitvoeren,die rechtstreeks of onrechtstreeks verband houden met haar voorwerp of activiteiten die zullen bijdragen tot haar ontwikkeling.
  15. De vennootschap zal de leiding en de controle,in haar hoedanigheid van bestuurder,vereffenaar of anderszins,kunnen uitoefenen over,en advies verschaffen aan aanverwante ondernemingen en dochtervennootschappen.
  16. De vennootschap mag bij wijze van inbreng in speciën of in natura,fusie,onderschrijving,deelneming,financiële tussenkomst of anderszins,belangen nemen in andere bestaande of op te richten vennootschappen of ondernemingen,in België of in het buitenland,waarvan het voorwerp verwant of analoog is met het hare of van aard haar voorwerp te bevorderen.
  17. De vennootschap kan zowel tot waarborg van eigen verbintenissen als tot waarborg van verbintenissen van derden borg stellen,onder meer door haar goederen in hypotheek of in pand te geven,inclusief de eigen handelszaak.

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
INSENTIALS
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, adres over te brengen naar tweetalig gebied Brussel Hoofdstad of Nederlands taalgebied door eenvoudige beslissing…” (deed in Dutch)

deed of 29-11-2024

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Gekozen uit B-bestuurders, collegiaal bestuursorgaan (Raad van Bestuur)” (deed in Dutch)
“Al dan niet ten kosteloze titel, algemene vergadering bepaalt bezoldiging beslissend met meerderheid van stemmen en rekening houdend met…” (deed in Dutch)

deed of 29-11-2024

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Op naam, register van aandelen op naam met wettelijk voorgeschreven vermeldingen” (deed in Dutch)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Aandelen, overdrachtsbeperkingen en procedures zoals opgenomen in Aandeelhouders-overeenkomst” (deed in Dutch)
Share issue ruleHow and by whom new shares can be issued.
“Overeenkomstig toepasselijke wetgeving en bepalingen in Aandeelhoudersovereenkomst, bestaande aandeelhouders” (deed in Dutch)

deed of 29-11-2024

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Friday of June

deed of 29-11-2024

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Vormen vereist voor statutenwijziging, ontbinding door beslissing algemene vergadering” (deed in Dutch)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
One provision in the deed

deed of 29-11-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Stortingsplicht, bepaalt vrij naargelang behoeften en op door hem bepaalde tijdstippen latere stortingen op in speciën onderschreven niet…” (deed in Dutch)
Other provision: “Ondeelbaarheid van effecten, één eigenaar per effect voor uitoefening aan aandeelhouders toegekende rechten” (deed in Dutch)
Other provision: “Dagelijks bestuur, op elk ogenblik ontslaan binnen beperkingen in Aandeelhoudersovereenkomst” (deed in Dutch)
Other provision: “Één of meerdere commissarissen, controle van vennootschap” (deed in Dutch)
Other provision: “Toegang algemene vergadering, rechten niet geschorst” (deed in Dutch)
Other provision: “Voorzitter,bij gebrek aanwezige aandeelhouder met meeste aandelen,bij pariteit oudste, zittingen-processen-verbaal” (deed in Dutch)
Other provision: “Elke aandeelhouder aan ieder ander persoon,al dan niet aandeelhouder,schriftelijk,door alle middelen van overdracht, beraadslagingen” (deed in Dutch)
Other provision: “Bestuursorgaan, tijdens zitting” (deed in Dutch)
Other provision: “Bestemming winst-reserves-interimdividenden, elk aandeel gelijk aandeel in winstverdeling” (deed in Dutch)
Liquidation distribution: “Behoudens afwijkingen artikel 5 en Aandeelhouders-overeenkomst, netto actief onder alle aandeelhouders naar verhouding aantal aandelen” (deed in Dutch)
Other provision: “Uitvoering statuten,alle mededelingen,aanmaningen,dagvaardingen en betekeningen geldig, woonstkeuze” (deed in Dutch)
Other provision: “Rechtbank in wiens rechtsgebied zetel gevestigd, betwisting zaken vennootschap en uitvoering statuten” (deed in Dutch)
Other provision: “Gemeen recht” (deed in Dutch)
Other provision: “Definities-Aandeelhoudersovereenkomst, tussen aandeelhouders gesloten” (deed in Dutch)
1 more provision in the deed, see the deed of 29-11-2024

deed of 29-11-2024